NeoGenomics Inc (NAS:NEO)
$ 17.74 0.56 (3.26%) Market Cap: 2.28 Bil Enterprise Value: 2.50 Bil PE Ratio: 0 PB Ratio: 2.50 GF Score: 74/100

Q1 2019 Neogenomics Inc Earnings Call Transcript

Apr 30, 2019 / 12:30PM GMT
Release Date Price: $20.83 (-0.29%)
Operator

Good day, ladies and gentlemen, and welcome to the NeoGenomics First Quarter 2019 Earnings Call. (Operator Instructions)

At this time, it is my pleasure to turn the floor over to your host for today, Mr. Doug VanOort. Sir, the floor is yours.

Douglas M. VanOort
NeoGenomics, Inc. - Chairman & CEO

Thank you, Jesse. Good morning. I'd like to welcome everyone to NeoGenomics First Quarter 2019 Conference Call. Joining me from our Fort Myers headquarters is Sharon Virag, our Chief Financial Officer; Rob Shovlin, President of our Clinical Services Division; and Bill Bonello, Chief Strategy and Corporate Development Officer and Director of Investor Relations. Joining us on the phone from Aliso Viejo is Dr. Larry Weiss, our Chief Scientific Officer.

Before we begin our prepared remarks, Bill Bonello will read the standard language about forward-looking statements.

William Bishop Bonello
NeoGenomics, Inc. - Chief Strategy & Corporate Development Officer and Director of IR

This conference call may

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot